TELA Bio Inc. (TELA)
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
Calidi Biotherapeutics - Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Owlet Baby Care Inc. - Owlet Reports Third Quarter 2025 Financial Results
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Owlet Reports Third Quarter 2025 Financial Results
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
Ainos Reports Third Quarter 2025 Financial Results
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
A New Press Release from Elicio Therapeutics
Omeros Corporation Reports Third Quarter 2025 Financial Results